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Abstract 
The membrane-bound human liver UDP-glucuronosyltransferase UGTl*6 was expressed in Escherichia colt’. Exchange of the natural signal peptide 
by the bacterial signal peptides of pelB or OmpT proteins considerably increased the level of expression and, as the natural signal peptide, targeted 
the protein to the membranes. The extent of maturation of “pelB-UGTl*6 precursor was about 30%. No processing of ‘OmpT-UGTl*6 occurred 
but the processing rate of this precursor could be significantly increased by mutagenesis of the first two amino acid residues of the mature sequence. 
These expression vectors allowed us to produce high levels of recombinant mature UGTl*6 required for further structural studies. 
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I. Introduction 
UDP-glucuronosyltransferase (UGT, EC 2.4.1.17), 
comprises a superfamily of isoenzymes, which detoxify 
a large variety of endogenous and foreign compounds 
[1,2]. Cloning and expression of the human liver 
UGT1*6 cDNA, one of the ten UGT cDNAs cloned to 
date in man, showed that this isoform presents a re- 
stricted specificity towards short and planar phenols and 
may therefore play a major role in the elimination of 
reactive molecular species [3-51. 
UGTs are integral membrane proteins located in the 
endoplasmic reticulum (ER) of various cells. Compari- 
*Corresponding author. Fax: (33) 83 32 13 22. 
Abbrenations: UGT, UDP-glucuronosyltransferase; PCR, polymerase 
chain reaction; IPTG, isopropyl-B-o-thiogalactopyranoside; PMSF, 
phenylmethylsulfonyl fluoride; RBS, ribosome binding site; EDTA, 
ethylenediaminetetraacetate: ER. endopasmic reticulum. 
UGTl*6 [1] (HLUGPl, trivial name for human liver UDPGT phenol 
1). The asterisk indicates that this isoform is derived from a primary 
transcript common to several isoforms encoded by the UGTl locus, by 
alternative splicing. 
son of UGT cDNAs sequences provided evidence for 
common topogenic elements proposed to mediate 
translocation and integration of UGT isoenzymes into 
the ER. Comparison of the N-terminal sequence of puri- 
fied proteins to primary sequences deduced from cDNA 
cloning suggested that UGTs are biosynthesized as pre- 
cursors with an amino-terminal signal peptide sequence. 
A stop-transfer sequence at the carboxy-terminal part of 
the protein stops the translocation and consequently in- 
tegrates the polypeptide in the ER via a transmembrane 
anchor segment [6,7]. 
The difficulties encountered in the purification of these 
phospholipid-dependent enzymes from human tissues 
have delayed their molecular characterization. However, 
heterologous expression of UGT cDNAs in eukaryotic 
cells has allowed functional characterization of the sub- 
strate specificity of individual UGTs, but did not provide 
sufficient amounts of recombinant product for further 
structural analysis [4,7,8]. Bacterial expression systems 
have been developed for many proteins to overcome this 
problem but the possible advantages of this system have 
not been investigated in the case of UGT yet. 
It has been shown that the export of heterologous 
proteins in E. coli may only require a correct protein 
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fusion between a prokaryotic signal peptide and the ma- 
ture portion of the foreign protein, with the only restric- 
tion that the expressed protein itself should be translo- 
cated in its natural context [9]. In this report, we devel- 
oped a bacterial expression system allowing the recovery 
of large amounts of a recombinant UGTI *6 protein and 
we examined the influence of the signal peptide on the 
level of production and on the processing of this protein 
expressed in E. co/i. Furthermore, we provide evidence 
for the importance of the two first amino acid residues 
at the N-terminus of the mature protein on the rate of 
processing. 
2. Materials and methods 
Isopropyl-/I-o-thtogalactopyranoside (IPTG) was from Boehrmger 
Restriction enzymes, T4 DNA hgase were purchased from New Eng- 
land Biolabs and Taq polymerase was from Perkin-Elmer Cetus. Cul- 
ture media for bacteria were from Difco. 
-7 1. Bacterial strain and expression vectors 
E coli strain BL21 (F- ompT rmB m-a )(DE3)pLysS was from No- 
vaeen. The oET-3d vector was kindlv nrovided bv Dr. F. W. Studter 
(Bpookhaven National Laboratory. Brookhaven, USA) [lS]. The PET- 
12a. PET-2Ob plasmids were from Novagen and the TA cloning kit 
from Invitrogen. 
2 2. Construction of the vector containmg the firll-length UGTlV 
cDNA (pUGTl*61 
Cloning and sequencmg of UGTl*6 cDNA have been reported else- 
where [3]. The cDNA sequence of UGTl*6 was amplified by polym- 
erase cham reaction (PCR) using the synthetic oligomer A. 5’- 
CGCCATGGCCTGCCTCCTTCGC-3’ as N-termmal primer. This 
primer was designed to create a NcoI site reqmred for subclonmg into 
the PET-3d vector and hybridized to a sequence encoding the first 6 
amino acid residues of the precursor protein The C-terminal primer B, 
5’-GCGGATCCTCAATGGGTCTTGGATTT-3’ hybridized to a se- 
quence-for the 5 last amino acid residues of the protem and 
contains a BamHI site for subcloning into the vector. Linearized 
pKCRH2-HLUGPl vector [3] was used as a template. The amplifica- 
tion was performed as follows: denaturation at 94°C for 1 min. anneal- 
mg at 55°C for 1 mm. gradual temperature increase to 72°C over a 
2-min period, and further primer extenston at 72°C for IO min. Ampli- 
fication was performed for 20 cycles (Perkin-Elmer Cetus). The PCR 
product was ligated into pCR II vector (TA cloning kit). This recombi- 
nant vector was then digested with Bsu361 and BamHI and the resulting 
fragment of 1490bp coding for 497 C-termmal amino acid residues was 
exchanged with the same fragment of the non-amplified sequence. 
Fmally. the vector was digested by NcoI and BumHI and the resulting 
modified cDNA, encoding UGT1*6 with its natural signal peptide was 
subcloned into NcoI and BumHI sites of PET-3d to generate 
pUGT1*6. 
2.3 Construction of the vector designed for the expression of L’GTI *6 
fused to OmpT signal peptide (pt UGTl*61 
The construction of ptUGTl*6 was performed according to the same 
strategy than that developed for pUGT1*6 described above, except that 
the oligomer C. S-GGTCGACGGACAAGCTGCTGGTGGTCCC- 
TCAG-3’ was used as N-terminal primer This primer contains a SalI 
site required for subcloning into the PET-12a vector and hybridized to 
a sequence encoding the first 8 amino acid residues of the mature 
sequence of the protein. For the mutagenesis of the first two amino acid 
residues (Asp-l. Lys-2) to (Pro-l. Glu-2) of the mature sequence of 
UGT1*6 in the “OmpT-UGT1*6 fusion. the followmg oligonucleotide 
D, 5’-GGTCGACGCCTGAACTGCTGGTGGTCCCTCAG-3’ was 
used as N-terminal primer. In both cases the PCR product was digested 
with Sal1 and BamHI generating a fragment coding for the mature 
native or mutated UGTl*6 protein, which was isolated and subcloned 
into Sun-BumHI sites of PET-12a in frame with the sequence coding 
for the OmpT signal peptide. 
2.4. Constructton of the vector designed for the expression of UGTl*6 
fused to pelB signal peptide (pb UGTl *6 ) 
The construction of pbUGT1*6 was performed according to the same 
strateuv than that develooed for ~uGTl”6 described above exceot that 
the syzthetic oligomer E: S-CG’CCATGGACAAGCTGCTGGTGG- 
TC-3’ was used as N-terminal mhts primer was designed to 
create a NcoI site and hybridized to a sequence encoding the first 6 
amino acid residues of the mature protein, The PCR product was 
digested with Ncol and BamHI generating a fragment coding for the 
mature UGT1*6 protein, which was isolated and subcloned into NcoI 
and BumHI sites of PET-2Ob in frame with the sequence coding for the 
pelB signal peptide. The final recombinant plasmids were sequenced 
and used for overexpression. 
2.5. Expression of the recombmant proteins 
The bacteria were grown m Luria-Bertani (LB, Difco) medium con- 
taining ampicillin (50 pg/ml) and chloramphenicol(25 pg/ml), at 37°C 
until an OD,, of 0.5-0.6 was reached. IPTG (0.4 mM) was added and 
the incubation was continuated for 2.5 h. The cells were harvested by 
centrifugation at 5.000 xg for 15 min at 4°C. 
2.6. Subcellular fractionatton 
The cells were resuspended m 50 mM Tris-HCl (pH 8.0) buffer 
containing 1 mM EDTA and 1 mM PMSF (lysis buffer) and were lysed 
by three 10-s pulses from a 0.5 cm diameter probe of a sonicator 
(Bioblock Vibra-cell) at 60% of maximal Dower. The sonicated lvsates 
were then centrifuged at 5,000 x g for 10 min to remove cell debris. The 
supernatants were further centrifuged at 12,000 x g for 20 min to pre- 
cipitate mclusion bodies [l I]. The supernatant of the 12,000 x g centrtf- 
ugation was subjected to a further 100.000 x g centrifugation for 60 min 
to separate cell membranes from cytosol, as previously described [12]. 
Sodium carbonate washes were carried out by-homogenization of mem- 
brane nellets in 100 mM NaCO, foH 11 .O). as ureviouslv described I1 31. 
Following incubation with fhe sodium carbonate solution on ice for lb 
min, membranes were pelleted again by centrifugation. 
2.7. Protein analysis 
Protein concentration was measured according to Bradford [l4] 
using Bio-Rad reagent with bovine serum albumin as standard. SDS- 
PAGE was performed according to Laemmli [15]. After electrophore- 
sis, the proteins were transferred onto Immobilon- PR membrane (Mil- 
lipore). Detection of the recombinant protein was carried out using 
polyclonal anti-rat liver anti-UGT antibodies and anti-sheep IgG 
(F~~zY)~-alkaline phosphatase conmgate (Jackson Immunoreagents) as 
secondary antibody as previously described [16]. 
3. Results 
The coding sequence of mature UGTl*6 protein was 
fused to the natural UGT1*6 signal peptide or to two 
different bacterial signal peptides, “OmpT and “pelB. The 
amino acid sequences of the signal peptides are listed in 
Fig. 1 and differ in the length, in the degree of hydropho- 
bicity of the core region and in the turn region preceeding 
the signal peptidase cleavage site. 
The expression cassettes used were under the control 
of the T7 gene 10 promoter and ribosome binding site 
[lo]. The production of UGTl”6 protein from these vec- 
tors was compared in the same bacterial strain 
BL21(DE3)pLysS and in identical culture conditions. 
The results of Western blot analysis of the cell lysates 
obtained from IPTG-induced cells using anti-UGT anti- 
bodies are illustrated in Fig. 2. Derepression by IPTG 
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Fig. 1. Schemaiic ~pr~entat~on of the expresston cassette contained in pUGTl%. ptUGTl% and pbUGTl”% constmzts designed to express 
UGTI *6 with natural and bacterial signal peptides in bacteria. The ribosome binding site (RBS) sequence is underlined. Mutated amina acid residues 
of the mature UGTi*6 sequence areindicaied by an asterisk. 
teins. A single polypeptide af an apparent molecular 
mass of 55,000 Da was produced from “OmpT-UGTl*6 
sequence {Fig. 2, lane a), whereas expression of “peiB- 
UGTl*6 gave rise to two polypeptides of 52,000 and 
55,000 Da (Fig. 2, lane b). In the case of the frill-length 
UGTlV cDNA, a single polypeptide of an apparent 
molecular mass of 52,000 Da was expressed at a lower 
level than in the previous cases (Fig. 2, lane c). Expres- 
sion of UGT1*6, as a mature form, from a truncated 
cDNA lacking the signal peptide coding sequence re- 
sulted in the appearance of a pofypeptide band exhibiting 
the same apparent molecular mass of 52,000 Da (data 
not shown). These results suggested that the natural sig- 
nal peptide was cleaved indicating that the precursor of 
UGTl*6 was correctly processed in bacteria (Fig. 2, lane 
c). Approximatively 30% of “pelBUGTl*6 precursor 
was processed (Fig. 2, lane b) but no maturation of 
“OmpT-UGT1*6 precursor was observed (Fig. 2, lane a). 
Interestingly, we have observed a significant matnra- 
tion of “OmpT-UGTt*6 when changing the first two 
amino acid residues (Asp- 1 3 Lys-2) of the mature protein 
into (Pro-l, Glu-2) of “OmpT-UGT1*6, as evidenced by 
the appearance of a second polypeptide of 52,000 Da 
recognized by immunoblot analysis (Fig. 3. lane c). This 
result suggested that the first two amino acid residues of 
the mature sequence were impartant for the conforma- 
tion of the cleavage site and that the “OmpT-UGT1*6 
protein was a poor substrate for the signal peptidase. 
The subcellular localization of the expressed UGT1*6 
proteins from the various constructs was determined by 
fractionation of IPTG-induced cell homogenates. Inter- 
estingly, the recombinant proteins were exclusively asso- 
ciated with the membrane fractions (Fig. 4). Treatment 
of the membrane fraction by sodium carbonate, a con- 
ventional treatment used to remove non-integral mem- 
brane proteins 1131, did not release any of the three re- 
combinant proteins from the membrane fractions. It is 
noteworthy that immunoblot. analysis of membranes 
containing the recombinant proteins expressed with bac- 
terial signal peptide showed that the processing of these 
polypeptides reached about 50% (Fig. 4, lane a and b). 
This was explained by the observation that part of the 
precursors “OmpT-UGTl*S and “pel&UGT1*6 precipi- 
tated as inclusion bodies (Fig. 4, lanes e and f). 
4. Discussion 
For the first time, the expression of a UGT isoform in 
a prokaryotic expression system was successfully 
achieved and the influence of the signaf peptide, which 
may affect the rate of synthesis and the fate of the 
heterologous membrane-bound protein UGTI *6 in E, 
coii, was investigated. 
For this purpose, expression plasmids carrying the 
coding sequence of mature human UGTl*6 fused to the 
Fig, 2. Expression of native and modified UGTl *6 in E. m% Western 
blot analysis was perform& on totat bacterial extracts harvested before 
and after KPTG-inductions Lane a, recombinant UGTl+S expressed 
from the ptUGTi*6 vector (25 @g protein); fane b, recombinant 
UGTl*6 expressed from pbUGTl% vector (25 pg protein); lane c, 
recombinant UGTl*6 expressed from pUGTI*6 vector (50 fig pro- 
tein); lane d, non-induced cells (50 pg protein). 
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Fig. 3. Processing of non-mutated and mutated “OmpT-UGTl*6 re- 
combinant proteins. Total bacterial extracts (25 fig protein per lane) 
harvested before and after ~PTG-induction were analyzed by SDS- 
PAGE followed by immunobIotting. Lane a, non-indu~d cells; lane b, 
recombinant UGT1*6 expressed from ptUGTi*G; lane c, recombinant 
UGTI*6 expressed from mutated ptUGT1*6. 
natural signal peptide of UGTl*6 and to two different 
efficient secretion signal sequences [X7] have been con- 
structed. The production of the two recombinant pro- 
teins “OmpT-UGTl*6 and “pelB-UGTl*6 was higher 
than that of the native protein derived from full-length 
UGTl*6 cDNA, demonstrating that the use of bacterial 
signal peptides is favorable for the recovery of large 
amounts of recombinant UGT protein. The relatively 
low yield of production of UGT1*6 with its own signal 
peptide may result from the instability of this precursor 
in bacteria and/or to poor translation initiation. 
In addition, the human UGTl”6 containing its natural 
signal peptide was apparently fully processed in bacteria. 
This result is in agreement with the hypothesis that 
UGTs are expressed as precursors with a cleaved signal 
sequence. As previously shown by Talmadge et al. 1181 
and by Watts et al. [ 191, E. coli leader peptidase correctly 
processed a pre-proinsulin and a mouse IgG K-Chain 
fragment precursor, respectively, suggesting that the rec- 
ognition between pre-proteins and leader peptidase was 
specific and conserved during evolution. 
When the mature sequence of UGTl*6 was fused with 
pelB signal peptide, significant amount of processed pro- 
tein was observed. The incomplete processing of this 
precursor could be due to the high rate production of this 
polypeptide, suggesting that the leader peptidase activity 
may be rate limiting. In the case of “OmpT-UGTl*6, no 
processing of the precursor occurred and we found that 
physiological parameters, such as temperature, duration 
of induction period and composition of the culture me- 
dium did not cause major changes in the extent of the 
maturation process. 
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Since signal peptides do not have a strict consensus 
sequence, one might expect these sequences to be fully 
interchangeable, but numerous studies, including our re- 
port, indicate that this is not the case. We provide further 
evidence that the primary sequence of the signal peptide 
must also be compatible with the mature polypeptide to 
which it is linked [20,21]. This observation may be ex- 
plained by thermodynamic onsiderations of the confor- 
mation of the precursors, a matter which really concerns 
the whole protein and not the signal peptide only [20]. 
Mutation studies provided evidence that a region 
around the cleavage site that includes the last four 
amino-acid residues of the signal sequence and up to the 
first two amino-acid residues of the mature sequence is 
known to be important in the processing of several pre- 
cursors [23]. In the case of the “OmpT-UGT1*6 presur- 
sor, the mutation of the two first amino acid residues of 
UGTl*6 mature sequence improved the maturation 
process providing further evidence that the sequence 
around the processing site is important for recognition 
by signal peptidase possibly due to the preference for 
some amino acid residues or merely for steric considera- 
tion. 
UGTl*6 synthesized from the natural precursor was 
associated to the bacterial membrane. In addition, both 
the precursors “OmpT-UGTl*6 and “pelB-UGT1*6 
were membrane-bound suggesting that cleavage of the 
signal peptide was not necessary for translocation, and 
that the leader peptidase did not catalyse the transloca- 
tion of pre-proteins accross the membrane [22]. Binding 
of the recombinant proteins to the membrane is probably 
due to the carboxy-terminal stop transfer sequence of the 
UGT1*6 protein i7], which abdlishes further expc ort and 
a b C d e f 
-1 
Fig. 4. Membrane localization of recombinant UGTl*6 expressed with 
natural and bacterial signal peptides. Subcellular fractions were pre- 
pared from bacteria harvested before and after ~PTG-induction and 
analyzed by immunobIott~ng. Lane a, membrane fraction from bacteria 
transformed with mutated ptUGT1*6 (25 yg protem): lane b, mem- 
brane fraction from bacteria transformed with pbUGT1*6 (25 pg pro- 
tein); lane c, membrane fraction from bacteria transformed with 
pUGT1’6 (5Opg protem); lane d, membrane fraction from non-trans- 
formed cells (50 mg protein); lane e, msoluble fraction from bacteria 
transformed with mutated ptUGT1’6 (25 pug protein); lane f, msoluble 
fraction from bacteria transformed with pbUGT1’6 (25 fig protein). 
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consequently integrates the protein into the membrane 
via the transmembrane anchor segment. 
This report describes for the first time the expression 
of a human UGT isoform in E. co/i. Targeting the pro- 
tein to the membranes, like in its natural environnement, 
was achieved by using natural and bacterial signal pep- 
tides. This approach will be applicable to the other mem- 
bers of this large family of isoenzymes and will provide 
appropriate tools for further structural and physico- 
chemical analysis. 
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